Acadian Asset Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-343
Closed -$22K 2263
2026
Q1
$22K Sell
343
-6,223
-95% -$567K ﹤0.01% 1945
2025
Q4
$850K Sell
6,566
-6,494
-50% -$891K ﹤0.01% 1150
2025
Q3
$1.4M Buy
+13,060
New +$1.42M ﹤0.01% 974
2025
Q2
Sell
-36,182
Closed -$3.2M 1853
2025
Q1
$3.2M Buy
36,182
+567
+2% +$49.2K 0.01% 625
2024
Q4
$2.73M Sell
35,615
-15,974
-31% -$1.12M 0.01% 698
2024
Q3
$2.19M Buy
51,589
+50,266
+3,799% +$1.7M 0.01% 720
2024
Q2
$34K Buy
+1,323
New +$25.1K ﹤0.01% 1641
2024
Q1
Sell
-61,548
Closed -$168K 1808
2023
Q4
$168K Buy
+61,548
New +$143K ﹤0.01% 1265
2023
Q1
Sell
-2,487
Closed -$21K 1994
2022
Q4
$21K Buy
+2,487
New +$54.8K ﹤0.01% 1708

Other funds holding WGS

Acadian Asset Management's WGS Position: Q2 2026 in Review

Acadian Asset Management sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 343 shares — an estimated $22K sold.

Acadian Asset Management first reported a position in WGS in Q4 2022 and held it in 9 quarters. The position peaked at $3.2M in Q1 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Acadian Asset Management reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Acadian Asset Management sold 343 GeneDx Holdings shares in Q2 2026, an estimated $22K.
  • Acadian Asset Management first reported a position in GeneDx Holdings in Q4 2022 and held it in 9 quarters.
  • Acadian Asset Management's GeneDx Holdings position peaked at $3.2M in Q1 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.